↓ Skip to main content

Safe and Effective Permeation Enhancers for Oral Drug Delivery

Overview of attention for article published in Pharmaceutical Research, December 2007
Altmetric Badge

Mentioned by

patent
7 patents

Citations

dimensions_citation
110 Dimensions

Readers on

mendeley
193 Mendeley
Title
Safe and Effective Permeation Enhancers for Oral Drug Delivery
Published in
Pharmaceutical Research, December 2007
DOI 10.1007/s11095-007-9488-9
Pubmed ID
Authors

Kathryn Whitehead, Natalie Karr, Samir Mitragotri

Abstract

The use of intestinal permeation enhancers to overcome the absorption challenges associated with oral drug delivery has been hampered by the notion that enhancer efficacy is directly linked to toxicity. This study attempts to gain insight into the principles governing the potency and toxicity behavior of enhancers. Fifty-one enhancers were selected from 11 chemical categories and their potency and toxicity were analyzed in Caco-2 monolayers at concentrations spanning three orders of magnitude. A small but significant fraction of the 153 enhancer formulations studied demonstrated unexpected but desired behavior, that is, substantial efficacy without marked toxicity. Our results revealed that both chemical category and concentration proved critical in determining the usefulness of many enhancers, and the concept of an enhancer's 'therapeutic window' is discussed. Several of the most promising enhancers identified by the study were tested for their effect on the transport of the marker molecules mannitol and 70 kDa dextran across Caco-2 cells and were capable of increasing permeability more than 10-fold. The results presented here underscore the potential of chemical permeation enhancers while providing valuable direction as to what classes and concentrations of compounds are of interest when searching for safe and effective additions to oral formulations.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 193 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 2%
United Kingdom 1 <1%
Denmark 1 <1%
Germany 1 <1%
Unknown 187 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 43 22%
Researcher 40 21%
Student > Master 19 10%
Student > Bachelor 18 9%
Student > Postgraduate 10 5%
Other 30 16%
Unknown 33 17%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 35 18%
Agricultural and Biological Sciences 27 14%
Medicine and Dentistry 22 11%
Chemistry 20 10%
Engineering 15 8%
Other 36 19%
Unknown 38 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 February 2020.
All research outputs
#7,510,637
of 22,940,083 outputs
Outputs from Pharmaceutical Research
#1,018
of 2,863 outputs
Outputs of similar age
#41,362
of 156,360 outputs
Outputs of similar age from Pharmaceutical Research
#9
of 19 outputs
Altmetric has tracked 22,940,083 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,863 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,360 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.